Drug and Gene Delivery Devices Market

Drug and Gene Delivery Devices Market, By Product (Sub-retinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-filled Syringe, and Infusion Bags), By Commercialized Drugs (Luxturna (Drug Delivery Devices), Yescarta (Drug Delivery Devices), Zolgensma (Drug Delivery Devices), Kymriah (Drug Delivery Devices), Provenge (Drug Delivery Devices), and Strimvelis (Drug Delivery Devices)), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


The field of drug and gene delivery involves the development and delivery of drugs, genes, and/or gene products that ultimately alter protein expression and function of the cells, tissues, and living organisms. Drug delivery devices are the tools used to deliver the drug through the specific route of administration. While, gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells.

Market Dynamics:

Rise in burden of chronic diseases, such as infectious disease, cardiovascular disease, cancer, and diabetes, increasing demand for drug or gene delivery devices, increasing funding for cell and gene therapies, and rise in approvals for gene therapies are major factors expected to augment the growth of the global drug and gene delivery devices market over the forecast period.

For instance, in November 2022, Imunon, Inc. and Acuitas Therapeutics signed an agreement to evaluate the combination of IMUNON’s PLACCINE nucleic acid vaccine constructs formulated with Acuitas’ proprietary lipid delivery technology. Under the agreement, IMUNON will evaluate administration of its vector constructs formulated in various Acuitas LNP formulations for gene expression and immunogenicity in murine models.

Key features of the study:

This report provides in-depth analysis of the global drug and gene delivery devices market, and provides market size (US$ Thousand) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.

It profiles key players in the global drug and gene delivery devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include Pfizer, Inc., Novartis AG, Kite Pharma, Inc., Bluebird bio, Inc., Becton, Amgen, Inc., Vericel Corporation, uniQure N.V., Spark Therapeutics, Inc., Renova Therapeutics, Orchard Therapeutics plc, Kolon Tissue Gene, Inc., Human Stem Cell Institute, Dendreon Pharmaceuticals, Dickinson and Company, Helixmith Co., Ltd (ViroMed Co., Ltd), Bausch & Lomb Incorporated, and Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), among others.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

The global drug and gene delivery devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug and gene delivery devices market.

Detailed Segmentation:

Global Drug and Gene Delivery Devices Market, By Product:

Sub-retinal Injection Cannula

Extension Tube

Intravenous Catheter

Sterile Insulin Syringe

Pre-filled Syringe

Infusion Bags

Global Drug and Gene Delivery Devices Market, By Commercialized Drugs:

Luxturna (Drug Delivery Devices)

Yescarta (Drug Delivery Devices)

Zolgensma (Drug Delivery Devices)

Kymriah (Drug Delivery Devices)

Provenge (Drug Delivery Devices)

Strimvelis (Drug Delivery Devices)

Global Drug and Gene Delivery Devices Market, By Region:

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Company Profiles:

Pfizer, Inc.

Novartis AG

Kite Pharma, Inc.

Bluebird bio, Inc.

Becton Dickinson and Company

Amgen, Inc.

Vericel Corporation

uniQure N.V.

Spark Therapeutics, Inc.

Renova Therapeutics

Orchard Therapeutics plc

Kolon Tissue Gene, Inc.

Human Stem Cell Institute

Dendreon Pharmaceuticals

Helixmith Co., Ltd (ViroMed Co., Ltd.)

Bausch & Lomb Incorporated

Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product
Market Snapshot, By Commercialized Drugs
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Rise in burden of chronic diseases across the globe
Stringent rules and regulations
Increasing demand for drug and gene delivery devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Drug and Gene Delivery Devices Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Drug and Gene Delivery Devices Market, By Product, 2018-2030, (US$ Thousand)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Sub-retinal Injection Cannula
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Extension Tube
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Intravenous Catheter
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Sterile Insulin Syringe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Pre-filled Syringe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Infusion Bags
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
6. Global Drug and Gene Delivery Devices Market, By Commercialized Drugs, 2018-2030, (US$ Thousand)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Luxturna (Drug Delivery Devices)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Yescarta (Drug Delivery Devices)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Zolgensma (Drug Delivery Devices)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Kymriah (Drug Delivery Devices)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Provenge (Drug Delivery Devices)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
Strimvelis (Drug Delivery Devices)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
7. Global Drug and Gene Delivery Devices Market, By Region, 2018-2030, (US$ Thousand)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
8. Competitive Landscape
Pfizer, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Kite Pharma, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bluebird bio, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Vericel Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
uniQure N.V.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Spark Therapeutics, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Renova Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Orchard Therapeutics plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Kolon Tissue Gene, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Human Stem Cell Institute
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Amgen, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Dendreon Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Helixmith Co.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bausch & Lomb Incorporated, Ltd. (ViroMed Co., Ltd.)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Becton Dickinson and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
9. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Drug and Gene Delivery Devices Market” - forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings